Journal ArticleOpen Access
Application of an Improved Method for the Recombinant K39 Enzyme-Linked Immunosorbent Assay To Detect Visceral Leishmaniasis Disease and Infection in Bangladesh
Authors
Author Affiliations
Centers for Disease Control and Prevention, National Center for Infectious Diseases, Division of Parasitic Diseases and Malaria, International Centre for Diarrhoeal Disease Research
Published InClinical and Vaccine Immunology
Year2005
Citations26
Abstract
Several serology-based immunoassays are used to diagnose visceral leishmaniasis (VL), a chronic protozoan parasitic disease caused by the Leishmania donovani complex. These tests are primarily designed to diagnose the most severe clinical form of VL, known as kala-azar. However, leishmanial infection is frequently asymptomatic and may manifest only as a positive serologic response or positive leishmanin skin test. We modified a previously described enzyme-linked immunosorbent assay (ELISA) that detects patient antibodies reactive with the recombinant Leishmania protein K39 (rK39) to confirm suspected kala-azar and to detect asymptomatic infection in a community study in Bangladesh. With the inclusion of a standard curve on each ELISA plate, the rK39 ELISA was more repeatable (kappa coefficient of agreement=0.970) and more reliable compared to…
View at Publisher
BORR does not host full-text PDFs. The button above takes you to the original publisher.